Research Output per year
Personal profile
Ancillary activities
No ancillary activities
Ancillary activities are updated daily
Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.
Biotechnology
Engineering & Materials Science
Innovation
Engineering & Materials Science
Pharmaceutical Preparations
Medicine & Life Sciences
Industry
Engineering & Materials Science
Technology
Medicine & Life Sciences
Drug products
Engineering & Materials Science
Sales
Engineering & Materials Science
Mergers and acquisitions
Engineering & Materials Science
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 2013 2017
The moderating role of absorptive capacity and the differential effects of acquisitions and alliances on Big Pharma firms' innovation performance
Fernald, K. D. S., Pennings, H. P. G., van den Bosch, J. F., Commandeur, H. R. & Claassen, H. J. H. M., 23 Feb 2017, In : PLoS ONE. 12, 2, p. e0172488Research output: Contribution to Journal › Article › Academic › peer-review
Open Access
Innovation
Biotechnology
Pharmaceutical Preparations
Industry
new drugs
Biotechnology Commercialization Strategies: Risk and Return in Interfirm Cooperation
Fernald, K. D. S., Pennings, H. P. G. & Claassen, E., 2015, In : Journal of Product Innovation Management. 32, 6, p. 971-996Research output: Contribution to Journal › Article › Academic › peer-review
Biotechnology
Innovation
Industry
Mergers and acquisitions
Product development
Trade-sale exits in different biotech sectors
Fernald, K. D. S. & Claassen, E., 2015, In : Nature Biotechnology. 33, p. 1221-1239Research output: Contribution to Journal › Article › Academic › peer-review
Venture capitalists as gatekeepers for biotechnological innovation
Fernald, K., Hoeben, R. & Claassen, H. J. H. M., 1 Jul 2015, In : Journal of Commercial Biotechnology. 21, 3, p. 32-41 10 p.Research output: Contribution to Journal › Article › Academic › peer-review
Innovation
Technology
Sales
Precision Medicine
Oncology
Biotechnology Commercialization Strategies: Risk and Return in interfirm cooperation.
Fernald, K. D. S., Pennings, E. & Claassen, E., 1 Sep 2014, In : Journal of Product Innovation Management.Research output: Contribution to Journal › Article › Academic › peer-review
Biotechnology
Innovation
Industry
Mergers and acquisitions
Product development